Edition:
United Kingdom

Renewable Fuels

Page 1

Deinove Takes On A Whole New Dimension With The Acquisition Of Morphochem's Clinical Stage Antibiotic Compound

Friday, 13 Apr 2018

April 13 (Reuters) - Deinove SA ::DEINOVE TAKES ON A WHOLE NEW DIMENSION WITH THE ACQUISITION OF MORPHOCHEM’S CLINICAL-STAGE ANTIBIOTIC COMPOUND.DEINOVE SA <<>>- ANNOUNCES ACQUISITION, THROUGH A CONTRIBUTION-IN-KIND TRANSACTION, OF ENTIRE CAPITAL OF AUSTRIAN COMPANY BIOVERTIS AG.DEINOVE SA <<>>- BIOVERTIS OWNS ENTIRE CAPITAL OF GERMAN COMPANY MORPHOCHEM, WITH LATTER DEVELOPING CLINICAL-STAGE ANTIBIOTIC COMPOUND "MCB3837".

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary